Insuficiencia renal aguda relacionada con medicamentos en pacientes hospitalizados

Singri, 2003, Acute renal failure, JAMA, 289, 747, 10.1001/jama.289.6.747 Lameire, 2005, Acute renal failure, Lancet, 365, 417, 10.1016/S0140-6736(05)70238-5 Bellomo, 2004, Acute renal failure-definition, outcome measures, animal models, fluid therapy and information thechnology needs: The Second International Consensus Coference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care, 8, R204, 10.1186/cc2872 Pruchnicki, 2002, Acute renal failure in hospitalized patients: Part I, Ann Pharmacother, 36, 1261, 10.1345/aph.1A339 Nash, 2002, Hospital-acquired renal insufficiency, Am J Kidney Dis, 39, 930, 10.1053/ajkd.2002.32766 Chertow, 2005, Acute kidney injury, mortality, length of stay and costs in hospitalized patients, J Am Soc Nephrol, 16, 3365, 10.1681/ASN.2004090740 Taber, 2008, The epidemiology of drug-induced disorders: The kidney, Expert Opin Drug Saf, 7, 679, 10.1517/14740330802410462 Kohli, 2000, Treatment-related acute renal failure in the elderly: A hospital-based prospective study, Nephrol Dial Transplant, 15, 212, 10.1093/ndt/15.2.212 Hou, 1983, Hospital-acquired renal insufficiency: A prospective study, Am J Med, 74, 243, 10.1016/0002-9343(83)90618-6 Shusterman, 1987, Risk factors and outcome of hospital-acquired acute renal failure Clinical epidemiologic study, Am J Med, 83, 65, 10.1016/0002-9343(87)90498-0 Lauzurica, 1989, Insuficiencia renal aguda producida en el hospital: estudio prospectivo y prevención de la misma, Med Clin (Barc), 92, 331 Jha, 1992, Spectrum of hospital-acquired acute renal failure in the developing countries--Chandigarh study, Q J Med, 83, 497 Barrantes, 2009, Acute kidney injury predicts outcomes of non-critically ill patients, Mayo Clin Proc, 84, 410, 10.1016/S0025-6196(11)60559-4 Abraham, 1989, Cause and prognosis of acute renal failure in Kuwait: A 2-year prospective study, J Trop Med Hyg, 92, 325 Liaño, 1996, Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Madrid. Acute Renal Failure Study Group, Kidney Int, 50, 811, 10.1038/ki.1996.380 Wang, 2012, Acute kidney injury and mortality in hospitalized patients, Am J Nephrol, 35, 349, 10.1159/000337487 ATC/DDD index 2014 [consultado 30 Nov 2014]. Disponible en: http://www.whocc.no/atc_ddd_index/ Classificació International de malalties, novena revició, modificació clínica (CIM-9-CM). Generalitat de Catalunya; Department of Sanidad i Seguritat Social. Barcelona: Servei català de la salud; 1997. Capellà, 1993, La notificación espontánea de RA a medicamentos, 147 Meyboom, 1992, Causality classification at pharmacovigilance centres in the European Community, Pharmacoepidemiol Drug Saf, 1, 87, 10.1002/pds.2630010207 Liaño García, 2007, Definiciones de FRA y terminología, Nefrologia, 27, 37 Hoste, 2006, Acute kidney injury: Epidemiology and diagnostic criteria, Curr Opin Crit Care, 12, 531, 10.1097/MCC.0b013e3280102af7 Choudhury, 2006, Drug-associated renal dysfunction and injury, Nat Clin Pract Nephrol, 2, 80, 10.1038/ncpneph0076 Naughton, 2008, Drug-induced nephrotoxicity, Am Fam Physician, 78, 743 Pannu, 2008, An overview of drug-induced acute kidney injury, Crit Care Med, 36, 216, 10.1097/CCM.0b013e318168e375 Perazella, 2009, Renal vulnerability to drug toxicity, Clin J Am Soc Nephrol, 4, 1275, 10.2215/CJN.02050309 Schetz, 2005, Drug-induced acute kidney injury, Curr Opin Crit Care, 11, 555, 10.1097/01.ccx.0000184300.68383.95 Loboz, 2005, Drug combinations and impaired renal function -- the ‘triple whammy’, Br J Clin Pharmacol, 59, 239, 10.1111/j.0306-5251.2004.2188.x Ishiguro, 2008, Assessing the effects of non-steroidal anti-inflammatory drugs on antihypertensive drug therapy using post-marketing surveillance database, J Epidemiol, 18, 119, 10.2188/jea.JE2007413 Lapi, 2013, Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: Nested case-control study, BMJ, 346, e8525, 10.1136/bmj.e8525 Meyer, 2006, Survillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): A summary of the data from 2001 through 2004, Infection, 34, 303, 10.1007/s15010-006-6619-x Ku, 2013, Correlations between aminoglycoside consumption and aminoglycoside resistance in Gram-negative bacteria at a tertiary-care hospital in South Korea from 2001 to 2011, Int J Antimicrob Agents, 41, 394, 10.1016/j.ijantimicag.2012.11.009 Leven, 2014, Prospective study of drug-induced interstitial nephritis in 11 French nephrology units, Presse Med, 43, e369, 10.1016/j.lpm.2014.03.032 Olyaei, 1999, Immunosuppressant-induced nephropathy: Pathophysiology, incidence and management, Drug Saf, 21, 471, 10.2165/00002018-199921060-00004 Olyaei, 2001, Nephrotoxicity of immunosuppressive drugs: New insight and preventive strategies, Curr Opin Crit Care, 7, 384, 10.1097/00075198-200112000-00003 Fliser, 2012, A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: Definitions, conservative management and contrast-induced nephropathy, Nephrol Dial Transplant, 27, 4263, 10.1093/ndt/gfs375 Barrett, 2006, Clinical practice. Preventing nephropathy induced by contrast medium, N Engl J Med, 354, 379, 10.1056/NEJMcp050801 McCullough, 2006, CIN Consensus Working Panel: Risk prediction of contrast-induced nephropathy, Am J Cardiol, 98, 27K, 10.1016/j.amjcard.2006.01.022